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Background: Infectious mononucleosis (IM) or Mononucleosis syndrome is caused by an acute infection of
Epstein-Barr virus. In Latin American countries, there are little information pertaining to the clinical manifestations
and complications of this disease. For this reason, the purpose of this work was to describe the clinical and
laboratory characteristics of infection by Epstein-Barr virus in Mexican children with infectious mononucleosis.
Methods: A descriptive study was carried out by reviewing the clinical files of patients less than 18 years old
with clinical and serological diagnosis of IM by Epstein-Barr virus from November, 1970 to July, 2011 in a third
level pediatric hospital in Mexico City.
Results: One hundred and sixty three cases of IM were found. The most frequent clinical signs were
lymphadenopathy (89.5%), fever (79.7%), general body pain (69.3%), pharyngitis (55.2%), hepatomegaly (47.2%).
The laboratory findings were lymphocytosis (41.7%), atypic lymphocytes (24.5%), and increased transaminases
(30.9%), there were no rupture of the spleen and no deaths among the 163 cases.
Conclusions: Our results revealed that IM appeared in earlier ages compared with that reported in industrialized
countries, where adolescents are the most affected group. Also, the order and frequency of the clinical
manifestations were different in our country than in industrialized ones.
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Infectious mononucleosis (IM) or Mononucleosis syn-
drome is caused by an acute infection of Epstein-Barr
virus (EBV). It has been reported that about 90% of the
cases is caused by EBV [1-3]. The natural infection by
EBV occurs only in humans and the result is a life-long
infection. In industrialized countries, there is greater
possibility of developing mononucleosis if EBV infection
occurs in the second decade of life. Seroepidemiological
studies have shown that about 91% of all adults world-
wide have had first-time infection by EBV. In developing
countries, first-time infection by EBV is more frequent* Correspondence: juarezol@yahoo.com
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distribution, and reproduction in any mediumin the first decade of life. The incidence of infectious
mononucleosis varies in each country in such a way that
in U.S.A., 500 cases per 100,000 inhabitants are reported
every year with a higher incidence in the age group from
15 to 24 years. Ebell [2], reported a higher incidence of
infectious mononucleosis in people from 10 to 19 years
old (6 to 8 cases per 1,000 people per year), and a lower
incidence in children less than 10 years old (1 case per
1,000 people per year) and a milder clinical manifesta-
tions which is frequently underdiagnosed [4-6]. The
transmission of EBV is principally through exposition to
infected saliva, and for such, it has been denominated
“kissing disease”.
The clinical manifestations of infectious mono-
nucleosis are characterized by fever, lymphadenopathy,
and pharyngitis and the duration of the infection is about
16 days, while the complications are variable. Hemato-
logical complications have been reported in 25% to 50% ofed Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Figure 1 Age of 163 patients included in the study grouped by age-ranges: A:0-2.5 years (y), B:2.5-5 y, C:5-7.5 y, D:7.5-10 y, E:10-12.5
y, F:12.5-15 y, G:15-17.5 y.
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thrombocytopenia, aplastic anemia, thrombotic thrombo-
cytopenic purpura, hemolytic uremic syndrome, and disse-
minated intravascular coagulation [5,6]. Neurologic
complications are seen in 1% to 5% of the cases, and in-
clude such complications as Guillain-Barre syndrome, fa-
cial paralysis, meningoencephalitis, aseptic meningitis,
transversal myelitis, peripheral neuritis, cerebellitis and
optical neuritis [6]. A potentially fatal complication is
splenic rupture, which has been reported in 0.5% to 1% of
the cases as well as air way obstruction (1% of the cases)
provoked by lymphoid hyperplasia and mucosal edema
[6]. In some occasions, EBV serves as a trigger for the
development of hemophagocytic lymphohistiocytosis
characterized by prolonged fever, lymphadenopathy, hepa-
tosplenomegaly, exanthem, hepatic dysfunction, and cyto-
penia. It is calculated that this problem is seen in
approximately 1 of every 800,000 people per year, and
includes all ages. In Latin American countries, there is lit-
tle information pertaining to the clinical manifestations
and complications of this disease. For this and other rea-
sons previously mentioned, the objective of this work wasFigure 2 Clinical manifestation of infectious mononucleosis in 163 pato describe the clinical and laboratory characteristics of
infection by Epstein-Barr virus in Mexican children with
infectious mononucleosis.Results
Two hundred and eighty three clinical files of patients
that were admitted at National Institute of Pediatrics,
Mexico City in the aforementioned period with clinical
diagnosis of infectious mononucleosis were reviewed.
Fulfillment of the inclusion criteria were found in 163 of
the patients corroborated through serological studies of
Epstein-Barr virus infection. The age range of the
patients included in the study was from 2 months to
17 years (Figure 1).
The clinical characteristics of the patients were vari-
able and some of these manifestations were present at
the time of admission at the Institute. Lymphadenopathy
was seen in 146 patients (89.5%); fever in 130 (79.7%);
general body pain 113 (69.3%); pharyngitis 90 (55.2%);
and hepatomegaly in 77 (47.2%). Other clinical data
obtained were: 60 (36.8%) cases with splenomegaly; 27tients attended at NIP from 1970 to 2011.
Table 1 Blood test in 163 patients with infectious
mononucleosis by EBV at National Institute of Pediatrics
from 1970 to 2011
Average Range
Leukocytes (cells/mm3) 9,424 500–41,000
Total Lymphocytes (cells/mm3) 4,248 200–31,600
Table 3 Hepatic function test in patients with infectious
mononucleosis by EBV
No. of cases (%) with
abnormal values
Transaminasesa 39 of 126 (30.9%)
Bilirubinsa 16 of 38 (42.1%)
a. These parameters were not evaluated in all the patients on admission, only
in those with clinical data of jaundice and/or hepatitis.
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and 1 (0.61%) conjunctivitis and edema (Figure 2).
From laboratory studies, the data of leucocytes, total
lymphocytes, and atypic lymphocytes were obtained on
admission. At the same time, the levels of transaminases
and bilirubin were registered. From this study, the
leukocyte count was between 500 and 41,000/mm3 with
an average value of 9,424 leukocytes/mm3 while total
lymphocyte count was between 200 and 31,600/mm3
with an average value of 4,248/mm3. Atypic lymphocyto-
sis (values of atypic lymphocytes greater than 15%) oc-
curred when leukocyte count were between 6,000 and
41,000/mm3. Lymphocytosis defined as lymphocyte
count greater or equal to 4,000cells/mm3 was found in
68 (41.7%) of the patients (Tables 1 and 2).
Test of liver function on admission revealed elevation
of transaminase very much above the normal level in 39
(30-9%) of 126 patients. Bilirubin was found in 16
(42.1%) of 38 cases subjected to the test. The determin-
ation of bilirubin as well as transaminase was not done
in all the cases on admission. It was performed only in
patients with clinical data of jaundice and/or hepatitis
(Table 3).
Complications were seen in 52 (38%) of the cases with
the principal findings secondary to an infection by EBV
being hematologic complications and within which the
most frequent were anemia and thrombocytopenia inci-
dent in 12 (7.3%) of the patients. Other complications
were: Hemophagocytic syndrome in 10 (6.1%); aplastic
anemia 8 (4.9%); thrombotic thrombocytopenic purpura
in 8 (4.9%); pneumonia 7 (4.3%) cases; air way obstruc-
tion 3 (1.8%) cases; hepatitis 3 (1.8%); seizures 3 (1.8%);
non-thrombocytopenic purpura in 2 (1.2%); encephalitis
1 (0.6%); myositis 1 (0.6%); lymphoproliferative syn-
drome 1 (0.6%); and other cases 3 (1.8%) (Figure 3). InTable 2 Lymphocytes and atypical lymphocytosis in 163
patients with Infectious mononucleosis by EBV at
National Institute of Pediatrics from 1970 to 2011
No. of cases (%) with
abnormal values
Presence of atypical lymphocytes1 40 of 163 (24.5%)
Lymphocytosis2 68 of 163 (41.7%)
1. Atypical lymphocyte figures greater than 15%.
2. Lymphocytosis defined as lymphocyte count greater or equal to 4,000
cells/mm3.this study, lymphadenopathy was found in 89.5%. Table 4
shows an overview of these clinical data and some other
reports. No death was registered during the period.Discussion
Infectious mononucleosis is traditionally characterized
by the triad of fever, lymphadenopathy, and pharyngitis.
Balfour in his studies described that 100% of the patients
with IM present pharyngitis [1]. In this study however,
only 55.2% of the cases presented this clinical manifest-
ation while lymphadenopathy was found to be the most
frequent clinical sign which was observed in 89.5% of
the cases. Moreover, the presence of IM was described
in the studies published in industrialized countries as a
sickness of the adolescents and young adults [1,7,8],
while our study is revealing that the age group mostly
affected is constituted by pre-school children with the
average age of presentation being 5.2 years old.
It is important to mention that there are no recent
studies in Latin American countries that focus on clin-
ical manifestations and complications of infectious
mononucleosis in children. However, the present study
is demonstrating that the clinical characteristics differ
from that reported in industrialized countries. In our
study, fever was found in 70.7% of the cases which was
different from 34% and 45% reported in the studies of
Balfour and Grotto respectively [1,9]. Pharyngitis was
seen only in half of the patients (55.2%) in this series
while in the study of Balfour [1], it was seen in 100% of
the group and only 73% in the study of Rea [10]. In the
case of lymphadenopathy, we found that 89.5% of the
cases had this manifestation which was similar to that
reported by Balfour [1], Grotto [9], and Gao [11], who
observed 95%, 88.0%, and 89.5% respectively in their
study.
With respect to the findings in physical exploration,
hepatomegaly was found in 47.2% while Balfour [1],
reported 25%, Grotto [9] 36.7%, and Rea 7% [10]. For
splenomegaly, our result of 36.8% was similar to that
reported by Balfour with 35% [1], varying greatly with
that of Grotto [10], who reported 53.3% and Gao [11],
with 47.4% while Rea [10], described only 7%. Our find-
ing of 16.5% cases of exanthem was similar to that
described by the authors [1,9-11]. However, the
Figure 3 Complications in 62 of 163 patients infectious mononucleosis attended at NIP from 1970 to 2011.
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with the data of 10% reported by Rea [10].
The presence of atypic lymphocytes above 15% is
highly an indicative of IM by EBV. In this study, 24.5%
of the cases presented this result which was similar to
the reports of other authors [12]. The elevation of trans-
aminase common to IM was seen in 30.9% of our cases,
a figure markedly less than that reported in other studies
where the figure was up to 80% [13-15]. Hyperbilirubi-
nemia, seen in 42.1% of our patients, was far different
from the result of Grotto [9], who found this alteration
in 14.9%. It is important to point out that transaminase
and bilirubin values were only measured in patients with
clinical data of jaundice and/or hepatitis.
Finally, the most frequent complications found in our
study were anemia and thrombocytopenia found in 7.3%
of the cases. Others were aplastic anemia, thromboticTable 4 Comparison of the clinical and laboratory in differen
secondary to Epstein-Barr virus














Palpebral edema 10 NR
Atypic Lymphocytosis NA 59.2
Transaminasemia NA 57.9
Hyperbilirubinemia NA 14.9
NR: Not reported. NA: Not analyzed.thrombocytopenic purpura, hemophagocytic syndrome,
lymphoproliferative syndrome and hepatitis. Although in
the literature, splenic rupture was described as compli-
cation (with a frequency between 0.5% and 1%)
[1,16,17], in this study and in our country in general, it
is not a complication seen in children, probably because
the presentation of mononucleosis is in younger children
and the risk of suffering from trauma is less in compari-
son with what occurs in industrialized countries.
Infectious mononucleosis in developing countries is
seen in earlier ages in comparison with what occurs in
industrialized countries where the incidence is higher
in adolescence. Moreover, the clinical signs occur with
differential frequency and the complications are dis-
tinct with the triad of fever, lymphadenopathy, and
pharyngitis being the most frequent as in developed
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Our results revealed that IM appeared in earlier ages
compared with that reported in industrialized countries,
where adolescents are the most affected group. Also, the
order and frequency of the clinical manifestations were
different in our country than in industrialized.Methods
All cases diagnosed as infectious mononucleosis second-
ary to Epstein-Barr virus with a compatible clinical
manifestation and serological confirmation in children
attended at National Institute of Pediatrics (NIP), Mex-
ico City from 6th November, 1970 to 30th July, 2011
were included in the study. The research protocol was
approved by the Ethics Committee of NIP, Mexico. The
clinical files of all the patients with the aforementioned
diagnosis in the period under study were retrospectively
reviewed and 163 cases were detected
Age, sex, and clinical characteristics as fever, conjunc-
tivitis, palpebral edema, jaundice, exanthem, splenomeg-
aly, hepatomegaly, pharyngitis, general body pain, and
lymphadenopathy as well as data about hemoglobin,
leucocytes, lymphocytes, atypic lymphocytes, platelets,
alanine aminotransferase, aspartate aminotransferase,
and bilirubin were obtained. Also, patients who either
had or did not have complications associated to the in-
fection by the virus as well as the mortality related to it,
were evaluated. In order to have uniform medical cri-
teria, we considered as a case of mononucleosis all
patients with fever, pharyngitis, and/or lymphadenop-
athy with positive serology of infection by Epstein-Barr
virus which was considered as confirmation of the diag-
nosis when at least one of the following markers: Viral
capsid antigen Immunoglobulin M (VCA IgM), Viral
capsid antigen Immunoglobulin G (VCA IgG), anti early
antigen (anti-EA) is positive. In one case, the diagnosis
was confirmed by in situ hybridization in biopsy of
lymphatic node. After capturing the data, their statistical
descriptions were elaborated and their frequencies and
averages were presented with their respective graphical
representations.
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